See more : Akatsuki Inc. (3932.T) Income Statement Analysis – Financial Results
Complete financial analysis of Inovalon Holdings, Inc. (INOV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Inovalon Holdings, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Olympio Metals Limited (OLY.AX) Income Statement Analysis – Financial Results
- Jasmine International Public Company Limited (JASUF) Income Statement Analysis – Financial Results
- Golden Arrow Merger Corp. (GAMCW) Income Statement Analysis – Financial Results
- Star Jets International, Inc. (JETR) Income Statement Analysis – Financial Results
- Aerojet Rocketdyne Holdings, Inc. (AJRD) Income Statement Analysis – Financial Results
Inovalon Holdings, Inc. (INOV)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: http://www.inovalon.com
About Inovalon Holdings, Inc.
Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately 988,000 physicians; 522,000 clinical facilities; and approximately 314 million individuals and 53 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 667.52M | 642.41M | 527.68M | 449.36M | 427.59M | 437.27M | 361.54M | 295.80M | 300.28M | 239.69M |
| Cost of Revenue | 167.82M | 167.81M | 144.83M | 151.05M | 159.17M | 146.14M | 112.76M | 120.05M | 101.19M | 102.70M |
| Gross Profit | 499.70M | 474.60M | 382.85M | 298.31M | 268.42M | 291.13M | 248.78M | 175.74M | 199.09M | 136.99M |
| Gross Profit Ratio | 74.86% | 73.88% | 72.55% | 66.39% | 62.78% | 66.58% | 68.81% | 59.41% | 66.30% | 57.15% |
| Research & Development | 33.50M | 33.69M | 28.64M | 27.38M | 29.15M | 22.33M | 23.13M | 21.19M | 15.50M | 14.86M |
| General & Administrative | 216.62M | 200.76M | 205.04M | 149.95M | 137.28M | 115.03M | 88.57M | 80.64M | 72.66M | 63.18M |
| Selling & Marketing | 62.94M | 62.41M | 45.53M | 34.10M | 27.08M | 14.68M | 7.14M | 5.95M | 6.79M | 6.75M |
| SG&A | 279.56M | 263.17M | 250.57M | 184.05M | 164.35M | 129.71M | 95.71M | 86.59M | 79.45M | 69.94M |
| Other Expenses | 114.93M | 108.25M | 96.73M | 53.09M | 37.28M | 22.63M | 19.88M | 15.52M | 12.90M | 11.23M |
| Operating Expenses | 427.99M | 405.11M | 375.94M | 264.52M | 230.79M | 174.68M | 138.72M | 123.30M | 107.85M | 96.02M |
| Cost & Expenses | 595.81M | 572.92M | 520.76M | 415.57M | 389.95M | 320.82M | 251.48M | 243.35M | 209.04M | 198.72M |
| Interest Income | 479.00K | 2.24M | 2.18M | 5.43M | 5.79M | 3.00M | 6.00K | 9.00K | 11.00K | 10.00K |
| Interest Expense | 56.18M | 65.83M | 50.90M | 6.23M | 5.07M | 4.42M | 1.34M | 79.00K | 129.00K | 62.00K |
| Depreciation & Amortization | 114.93M | 108.25M | 96.73M | 53.09M | 37.28M | 22.63M | 19.88M | 15.52M | 12.90M | 11.23M |
| EBITDA | 186.56M | 179.96M | 94.07M | 91.90M | 81.25M | 141.76M | 129.95M | 67.97M | 104.15M | 52.21M |
| EBITDA Ratio | 27.95% | 28.01% | 17.83% | 20.45% | 19.00% | 32.42% | 35.94% | 22.98% | 34.68% | 21.78% |
| Operating Income | 71.71M | 69.49M | 6.92M | 33.79M | 37.63M | 116.46M | 110.06M | 52.45M | 91.24M | 40.97M |
| Operating Income Ratio | 10.74% | 10.82% | 1.31% | 7.52% | 8.80% | 26.63% | 30.44% | 17.73% | 30.38% | 17.09% |
| Total Other Income/Expenses | -56.25M | -63.61M | -60.47M | -1.20M | 1.27M | -1.75M | -1.33M | -70.00K | -118.00K | -52.00K |
| Income Before Tax | 15.46M | 5.88M | -53.56M | 32.59M | 38.90M | 114.71M | 108.73M | 52.38M | 91.12M | 40.92M |
| Income Before Tax Ratio | 2.32% | 0.91% | -10.15% | 7.25% | 9.10% | 26.23% | 30.07% | 17.71% | 30.34% | 17.07% |
| Income Tax Expense | -7.12M | -1.90M | -14.39M | -2.23M | 11.80M | 48.65M | 43.38M | 19.66M | 35.96M | 15.99M |
| Net Income | 22.58M | 7.78M | -39.16M | 34.82M | 27.10M | 66.06M | 65.35M | 32.72M | 55.16M | 24.93M |
| Net Income Ratio | 3.38% | 1.21% | -7.42% | 7.75% | 6.34% | 15.11% | 18.08% | 11.06% | 18.37% | 10.40% |
| EPS | 0.15 | 0.05 | -0.27 | 0.24 | 0.18 | 0.45 | 0.53 | 1.47 | 2.48 | 1.12 |
| EPS Diluted | 0.15 | 0.05 | -0.27 | 0.24 | 0.18 | 0.45 | 0.53 | 1.47 | 2.48 | 1.12 |
| Weighted Avg Shares Out | 149.72M | 148.63M | 145.39M | 142.23M | 150.05M | 145.75M | 122.26M | 22.22M | 22.22M | 22.22M |
| Weighted Avg Shares Out (Dil) | 149.72M | 148.63M | 145.39M | 142.74M | 150.96M | 148.28M | 122.26M | 22.22M | 22.22M | 22.22M |
Inovalon Holdings, Inc. (INOV) CEO Dr. Keith Dunleavy on Q2 2021 Results - Earnings Call Transcript
Recap: Inovalon Holdings Q2 Earnings
Inovalon Reports Second Quarter 2021 Results
INOV Stock Increases Over 14% Intraday: Why It Happened
Inovalon Announces Second Quarter 2021 Earnings Conference Call
Inovalon Announces Appointment of Eron S. Kelly as Corporate President
Walmart (WMT) Expands Partnership With Inovalon to Drive Growth
Walmart Extends Use of the Inovalon ONE® Platform
Inovalon and Homecare Homebase Announce Multi-Year Exclusive Agreement
Inovalon Receives Key Patent Award for On-Demand Real-Time Patient-Specific Data Aggregation and Analysis
Source: https://incomestatements.info
Category: Stock Reports